PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19

Jun 17, 2020

Posted by PTC Therapeutics, Inc.

IDDI Partner at the Proventa Clinical Operations Online Strategy Meeting

Jun 17, 2020

SPEAKING: IDDI at DIA Global

Jun 16, 2020

Asymmetrex Announces Plans to Provide Free Tissue Stem Cell Counting

Jun 16, 2020

Cresset and InoCardia to develop in silico cardiac safety assay for drug candidate screening

Jun 11, 2020

Posted by Cresset

Flare™ V4 release: Smarter and faster FEP calculations, new and improved force fields, improved Dynamics analysis tools

Jun 11, 2020

Posted by Cresset

PTC Therapeutics Launches New “Talent Pipeline Program” to Help Students who Graduated During the 2020 COVID-19 Pandemic

Jun 11, 2020

Posted by PTC Therapeutics, Inc.

CureDuchenne Ventures Announces The “CureDuchenne Ventures 2020 Pitch Contest”

Jun 10, 2020

Posted by CureDuchenne